Meropenem Kalceks

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem antibiotic presented as an intravenous formulation for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis and sepsis in hospitalized patients.

GNH USA supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

Complicated intra‑abdominal infections: provides rapid bacterial eradication to resolve intra‑abdominal sepsis. Complicated urinary tract infections: eliminates resistant uropathogens causing severe UTIs. Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other agents. Meningitis: penetrates the cerebrospinal fluid to clear bacterial meningitis. Severe sepsis and septic shock: offers immediate bactericidal activity in life‑threatening systemic infections.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Nausea or vomiting - Diarrhea, including mild colitis - Rash or mild skin erythema - Headache or dizziness - Elevated liver enzymes - Injection‑site phlebitis

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders or renal impairment - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Severe neutropenia or agranulocytosis - Renal toxicity or worsening renal function - Hepatic failure or cholestatic jaundice

Use meropenem with clinical monitoring and appropriate laboratory assessments.

Renal function monitoring: assess creatinine clearance before and during therapy. Dose adjustment in renal impairment: modify dosage according to renal function. CNS caution: avoid in patients with a history of seizures or epilepsy. Hypersensitivity warning: discontinue if allergic reactions develop. Superinfection risk: monitor for secondary infections such as fungal overgrowth. Store at below 25°C: keep in original packaging, protect from moisture and light.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: increased risk of seizures. - Probenecid: reduced renal clearance of meropenem, raising plasma levels. - Carbapenem‑inhibiting agents: antagonistic effect on antibacterial activity.

Moderate Interactions (Monitor Closely): - Loop diuretics: potential additive nephrotoxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may impair renal function when combined.